Abstract
In 39 of 100 cancer patients admitted to the palliative care unit at Edmonton General Hospital, the presence of delirium during their last week of life required psychotropic drug treatment. In 10 of the 39 delirious patients, symptoms were only controllable by sedation; this was achieved in 9 patients by a continuous subcutaneous infusion of midazolam. Although haloperidol is considered to be the treatment of choice in agitated, delirious cancer patients, our data suggest that palliative care treatment strategies for these patients may be different.
Original language | English (US) |
---|---|
Pages (from-to) | 94-98 |
Number of pages | 5 |
Journal | Journal of pain and symptom management |
Volume | 7 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1992 |
Externally published | Yes |
Keywords
- Delirium
- cancer
- midazolam
- psychotropic drug
ASJC Scopus subject areas
- General Nursing
- Clinical Neurology
- Anesthesiology and Pain Medicine